Skip to content

Clinical trials

Completed Genetic Diseases, Inborn trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Status: Completed Country / region: Germany Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20071
20081
20096
20102
20112
20121
20131
20141
20151
20163
20175
20187
20192
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vertex Pharmaceuticals Incorporated5
Novo Nordisk A/S4
GenSight Biologics3
BioMarin Pharmaceutical2
Genzyme, a Sanofi Company2
Novartis Pharmaceuticals2
Pfizer2
Regeneron Pharmaceuticals2
Alexion Pharmaceuticals, Inc.1
Alnylam Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn36
Nervous System Diseases7
Infant, Newborn, Diseases6
Musculoskeletal Diseases6
Eye Diseases5
Eye Diseases, Hereditary5
Hematologic Diseases5
Metabolic Diseases5
Metabolism, Inborn Errors5
Blood Coagulation Disorders4

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.